Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2010
08/05/2010US20100196352 Composition for increasing stamina
08/05/2010US20100196351 Secreted pate-like proteins
08/05/2010US20100196349 Reeler domain containing protein
08/05/2010US20100196348 COMBINATION TREATMENT WITH t-PA VARIANT AND LOW MOLECULAR WEIGHT HEPARIN
08/05/2010US20100196347 Bone grafts with reduced protease activity and methods of selection and use
08/05/2010US20100196346 Novel substrate for rpn 11 enzymatic activity
08/05/2010US20100196345 Production of high mannose proteins in plant culture
08/05/2010US20100196344 Compositions and methods for treating pancreatic insufficiency
08/05/2010US20100196343 Compositions, methods, devices, and systems for skin care
08/05/2010US20100196332 Generation of brachial, thoracic and lumbar spinal motor neurons from embryonic stem cells in the absence of all-trans retinoic acid supplement
08/05/2010US20100196331 Compositions including anthocyanin or anthocyanidin for the prevention or treatment of articular cartilage-associated conditions
08/05/2010US20100196324 Multifunctional cytokines
08/05/2010US20100196321 Compounds
08/05/2010US20100196320 Interferon aplpha sequential regimen for treating cancers
08/05/2010US20100196319 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
08/05/2010US20100196318 Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab
08/05/2010US20100196317 Cyclic undecapeptides and derivatives as multiple sclerosis therapies
08/05/2010US20100196316 Cyclosporin analogues for preventing or treating hepatitis c infection
08/05/2010US20100196315 IL-12/p40 BINDING PROTEINS
08/05/2010US20100196314 Modified Two-Component Gelation Systems, Methods of Use and Methods of Manufacture
08/05/2010US20100196313 Modified Two-Component Gelation Systems, Methods of Use and Methods of Manufacture
08/05/2010US20100196312 Glycosylated il-7, preparation and uses
08/05/2010US20100196311 METHODS AND COMPOSITIONS CONTAINING mTOR INHIBITORS FOR ENHANCING IMMUNE RESPONSES
08/05/2010US20100196310 Methods of treating cancer by administering human il-18 combinations
08/05/2010US20100196309 Interleukin-21 variants with altered binding to the il-21 receptor
08/05/2010US20100196308 Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
08/05/2010US20100196293 Use of an active principle originating from flax in a composition intended to reinforce the barrier function of the skin and to protect the skin and the appendages against external aggressions
08/05/2010US20100196287 Compositions Comprising Perhydrolases and Alkylene Glycol Diacetates
08/05/2010US20100196280 Functionalized solid polymer nanoparticles for diagnostic and therapeutic applications
08/05/2010US20100196267 Humanized L243 Antibodies
08/05/2010US20100196266 Humanized Anti-HLA-DR Antibodies
08/05/2010US20100196264 Use of somatostatin analogs in myocardial perfusion imaging
08/05/2010DE202009017877U1 Lektinzusammensetzung zur Prophylaxe und/oder Behandlung von unerwünschten Arzneimittelnebenwirkungen Lektinzusammensetzung for the prophylaxis and / or treatment of adverse drug side effects
08/05/2010DE102009006594A1 Pharmaceutical preparation, useful for the treatment of digestive disorders, cystic fibrosis and pancreatitis, comprises a liquid dosage form of enzymes
08/05/2010CA2751210A1 Cyclosporin analogues for preventing or treating hepatitis c infection
08/05/2010CA2750988A1 Tslp promotes immune evasion and persistence of viruses
08/05/2010CA2750983A1 Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
08/05/2010CA2750928A1 Methods of diagnosing and treating neurodegenerative diseases
08/05/2010CA2750811A1 Alanine-glyoxylate aminotransferase therapeutics
08/05/2010CA2750696A1 Use of a synergistic combination of hypothiocyanite and/or hypohalite ions and lactoferrin for preparing a treatment for cystic fibrosis
08/05/2010CA2750659A1 Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
08/05/2010CA2750576A1 Novel peptides and methods for producing them
08/05/2010CA2750409A1 Conformationally dynamic peptides
08/05/2010CA2750269A1 Crystalline insulin-conjugates
08/05/2010CA2749966A1 Il-1 binding proteins
08/04/2010EP2214013A1 Methods of treating bone disorders
08/04/2010EP2213746A1 Cell for use in the production of exogenous protein, and production process using the cell
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213742A1 Chimeric antigens for breaking host tolerance to foreign antigens
08/04/2010EP2213740A1 Human telomerase catalytic subunit
08/04/2010EP2213733A2 Factor IX analogues having prolonged in vivo half life
08/04/2010EP2213682A1 TSLP promotes immune evasion and persistence of viruses
08/04/2010EP2213680A1 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
08/04/2010EP2213301A1 Immune response inducer
08/04/2010EP2213297A1 Staphylococcus aureus antigenic polypeptides
08/04/2010EP2213296A1 Medicinal composition containing highly functionalized chimeric protein
08/04/2010EP2213295A1 A method for obtaining data useful in the identification of a patient at risk of having difficulty in sustaining a pregnancy
08/04/2010EP2213291A1 Antisense inhibition of PTP1B expression
08/04/2010EP2213284A1 Preparation for application to body surface and preparation holding sheet for application to body surface
08/04/2010EP2213280A1 Formulations comprising glucosinolate and myrosinase
08/04/2010EP2212352A1 New synthetic arginine substituted peptides and their use
08/04/2010EP2212351A1 Oxidant resistant apolipoprotein a-1 and mimetic peptides
08/04/2010EP2212350A1 Therapeutic and diagnostic methods using tim-3
08/04/2010EP2212344A2 Use of slit, nephrin, ephrin or semaphorin for treatment of cartilage diseases
08/04/2010EP2212343A2 Peptide gap junction modulators
08/04/2010EP2212334A1 Proteasome inhibitors
08/04/2010EP2211913A2 Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors
08/04/2010EP2211898A2 Novel patient subgroups for thrombolysis
08/04/2010EP2211897A1 Altered n-cadherin processing in tumor cells by furin and proprotein convertase 5a (pc5a)
08/04/2010EP2211894A2 Inhibition of urokinase-type plasminogen activator (upa) activity
08/04/2010EP2211893A2 Peptide compounds for treating obesity and insulin resistance
08/04/2010EP2211892A2 Composition
08/04/2010EP2211891A2 Antagonists of kisspeptin and uses thereof
08/04/2010EP2211890A1 Methods of treating urogenital-neurological disorders using modified clostridial toxins
08/04/2010EP2211889A2 Antibody-mediated disruption of quorum sensing in bacteria
08/04/2010EP2211888A1 Albumin fusion proteins
08/04/2010EP2211887A1 Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces
08/04/2010EP2211886A2 Human anti-amyloid antibodies, compositions, methods and uses
08/04/2010EP2211851A2 Laminins, derivatives, and compositions including same and method for their therapeutic use
08/04/2010EP2062598B1 Gel type enteric nutrient
08/04/2010EP1901759B1 Immunostimulatory method
08/04/2010EP1694360B1 Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases and organ transplant rejection
08/04/2010EP1636365B1 Cholesterol biosynthesis pathway modulators and uses thereof
08/04/2010EP1587539B1 Antimicrobial composition for local use on mucosal membranes and skin
08/04/2010EP1497797B1 A human protein kinase family member and uses therefor
08/04/2010EP1460134B1 SUGAR TRANSFERASE GnT-V HAVING ANGIOGENIC EFFECT
08/04/2010EP1419239B1 Mullerian inhibiting substance levels and ovarian response
08/04/2010EP1032675B1 Attaching substances to micro-organisms
08/04/2010CN201537287U Thymosin alpha 1 preparation
08/04/2010CN1906302B Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS
08/04/2010CN1896094B Use of angiotensin II receptors I immunogenic peptide section
08/04/2010CN1809377B Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
08/04/2010CN101796417A Cosmetic use of apolipoprotein D type proteins
08/04/2010CN101796183A Ace2多肽 Ace2 polypeptide
08/04/2010CN101796069A Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) with high selectivity and decrease the in vivo DTH-responses in rats
08/04/2010CN101796067A Lantibiotic-based compounds having antimicrobial activity
08/04/2010CN101795704A Oral composition
08/04/2010CN101795703A peptide tyrosinase inhibitors and uses thereof
08/04/2010CN101795702A Oligopeptide tyrosinase inhibitors and uses thereof
08/04/2010CN101795701A Inhibitors of acetyl-COA carboxylase for treatment of neuronal hypometabolism
1 ... 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 ... 3163